CCL2 and chronic kidney disease: As urinary EGF and MCP-1 levels are significantly correlated with their corresponding intrarenal mRNA levels (14, 32), the identified networks also provide molecular mechanistic support for the association of urinary EGF and MCP-1 with the composite CKD outcome.